Onkar Singh
J.C. Bose University of Science & Technology, YMCA(IN)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Cancer therapeutics and mechanisms, Biomedical Text Mining and Ontologies, Protein Structure and Dynamics
Most-Cited Works
- → Type IIA topoisomerase inhibition by a new class of antibacterial agents(2010)819 cited
- → Selective Plasma Hydrolysis of Glucocorticoid γ-Lactones and Cyclic Carbonates by the Enzyme Paraoxonase: An Ideal Plasma Inactivation Mechanism(1999)180 cited
- → The high-resolution crystal structure of a 24-kDa gyrase B fragment fromE. coli complexed with one of the most potent coumarin inhibitors, clorobiocin(1997)150 cited
- → Comparison of Multivariable Logistic Regression and Other Machine Learning Algorithms for Prognostic Prediction Studies in Pregnancy Care: Systematic Review and Meta-Analysis(2020)129 cited
- → Overview of the interactive task in BioCreative V(2016)99 cited
- → Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate(2007)90 cited
- → Design and Synthesis of Pyrrolidine-5,5-trans-lactams (5-Oxohexahydropyrrolo[3,2-b]pyrroles) as Novel Mechanism-Based Inhibitors of Human Cytomegalovirus Protease. 2. Potency and Chirality(2001)72 cited
- → In Vitro Resistance Selections for Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors Give Mutants with Multiple Point Mutations in the Drug-binding Site and Altered Growth(2014)69 cited
- → Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives(2016)67 cited
- → Crystallizing Membrane Proteins in the Lipidic Mesophase. Experience with Human Prostaglandin E2 Synthase 1 and an Evolving Strategy(2014)65 cited